Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03315494 · ClinicalTrials.gov registry record · Phase 1
Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of SKI-O-703 in Healthy Volunteers
A Phase 1 study, sponsored by Oscotec.
- Completed
- Registry status
- Phase 1
- Development phase
- 24
- Enrollment target
NCT03315494 is a Phase 1 study that has completed, run by Oscotec. The registered enrollment target is 24 participants.
The verdict
NCT03315494, a Phase 1 study, has completed, sponsored by Oscotec.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 24 participants
- Enrollment target
Study Summary
This double-blind, placebo-controlled, multiple ascending dose study is designed to evaluate the safety, tolerability, and pharmacokinetics (PK) of SKI-O-703 in healthy volunteers.
Interventions
- DRUG Placebo capsule
- DRUG SKI-O-703 capsule
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2016-09-22 |
| Est. Completion | 2016-12-21 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03315494
The ClinicalTrials.gov registry entry for NCT03315494 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oscotec, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo capsule is the first listed.
NCT03315494 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03315494 about?
NCT03315494 is a clinical study titled "Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of SKI-O-703 in Healthy Volunteers". This double-blind, placebo-controlled, multiple ascending dose study is designed to evaluate the safety, tolerability, and pharmacokinetics (PK) of SKI-O-703 in healthy volunteers.
What is the current status of trial NCT03315494?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 24 participants. The study started on 2016-09-22. Estimated completion is 2016-12-21.
What interventions are being tested in trial NCT03315494?
The interventions under investigation include: Placebo capsule (DRUG), SKI-O-703 capsule (DRUG).
Who is sponsoring clinical trial NCT03315494?
This trial is sponsored by Oscotec, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.